These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lymphocyte subset analysis in QuantiFERON-TB Gold Plus and T-Spot.TB for latent tuberculosis infection in rheumatoid arthritis. Igari H, Ishikawa S, Nakazawa T, Oya Y, Futami H, Tsuyuzaki M, Suzuki K, Matsumura R. J Infect Chemother; 2018 Feb; 24(2):110-116. PubMed ID: 29054459 [Abstract] [Full Text] [Related]
3. Role of CD8 T-cell in immune response to tuberculosis-specific antigen in QuantiFERON-TB Gold Plus. Tsuyuzaki M, Igari H, Okada N, Suzuki K. J Infect Chemother; 2020 Jun; 26(6):570-574. PubMed ID: 32067903 [Abstract] [Full Text] [Related]
4. Comparison of interferon-γ release assays, QuantiFERON TB-GIT and T-Spot.TB, in renal transplantation. Ishikawa S, Igari H, Akutsu N, Tsuyuzaki M, Aoyama H, Hasegawa M, Otsuki K, Maruyama M, Saigo K, Suzuki K, Yamagishi F. J Infect Chemother; 2017 Jul; 23(7):468-473. PubMed ID: 28438462 [Abstract] [Full Text] [Related]
6. Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients. Ryu MR, Park MS, Cho EH, Jung CW, Kim K, Kim SJ, Oh HY, Huh W, Jang HR, Koh WJ, Park HY, Kim YH, Sinn DH, Choi JO, Joh JW, Kim JM, Kim SJ, Park JB, Kang ES. J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30135226 [Abstract] [Full Text] [Related]
11. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country. Lin WC, Lin HH, Lee SS, Sy CL, Wu KS, Chen JK, Tsai HC, Chen YS. J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858 [Abstract] [Full Text] [Related]
12. Characterization of the CD4 and CD8 T-cell response in the QuantiFERON-TB Gold Plus kit. Petruccioli E, Chiacchio T, Pepponi I, Vanini V, Urso R, Cuzzi G, Barcellini L, Palmieri F, Cirillo DM, Ippolito G, Goletti D. Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S25-S26. PubMed ID: 28043588 [Abstract] [Full Text] [Related]
15. Accuracy of QuantiFERON-TB Gold Plus Test for Diagnosis of Mycobacterium tuberculosis Infection in Children. Buonsenso D, Delogu G, Perricone C, Grossi R, Careddu A, De Maio F, Palucci I, Sanguinetti M, Valentini P, Sali M. J Clin Microbiol; 2020 May 26; 58(6):. PubMed ID: 32229602 [Abstract] [Full Text] [Related]
17. Variation in interferon-γ production between QFT-Plus and QFT-GIT assays in TB contact investigation. Tsuyuzaki M, Igari H, Okada N, Suzuki K. Respir Investig; 2019 Nov 26; 57(6):561-565. PubMed ID: 31402331 [Abstract] [Full Text] [Related]
19. Diagnostic potential of interferon-gamma release assay to detect latent tuberculosis infection in kidney transplant recipients. Edathodu J, Varghese B, Alrajhi AA, Shoukri M, Nazmi A, Elgamal H, Aleid H, Alrabiah F, Ashraff A, Mahmoud I, Al-Hajoj S. Transpl Infect Dis; 2017 Apr 26; 19(2):. PubMed ID: 28170135 [Abstract] [Full Text] [Related]
20. Clinical evaluation of QuantiFERON®-TB Gold Plus directly compared with QuantiFERON®-TB Gold In-Tube and T-Spot®.TB for active pulmonary tuberculosis in the elderly. Fukushima K, Kubo T, Akagi K, Miyashita R, Kondo A, Ehara N, Takazono T, Sakamoto N, Mukae H. J Infect Chemother; 2021 Dec 26; 27(12):1716-1722. PubMed ID: 34412981 [Abstract] [Full Text] [Related] Page: [Next] [New Search]